NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: Innovotech Inc.'s Application for OTCQB Venture Market Trading
TL;DR
Innovotech's OTCQB listing offers investors early access to a growing Canadian biotech leader, potentially increasing share liquidity and U.S. market exposure.
Innovotech will list on OTCQB while maintaining its TSXV listing, using foreign issuer exemptions to avoid additional compliance burdens for U.S. trading.
By expanding access to U.S. investors, Innovotech can accelerate development of its biofilm science technologies that combat antimicrobial resistance globally.
A Canadian biofilm science company is making its stock available to U.S. investors through the OTCQB market with simplified electronic settlement.
Found this article helpful?
Share it with your network and spread the knowledge!
Innovotech Inc. announces its intention to obtain a stock quotation and trading symbol on the OTCQB Venture Market in the United States, which will operate in parallel with its primary Canadian listing on the TSXV.
The company aims to enhance its visibility to the U.S. investment community, make its shares more accessible to retail and institutional investors in the United States, and increase the liquidity of its common shares.
The OTCQB quotation is expected to impose no additional material compliance or reporting requirements, as Innovotech will continue to meet its existing primary market disclosure obligations on SEDAR+, which satisfy OTC market requirements under foreign issuer exemptions.
Companies must meet certain financial standards, be current in their reporting obligations, and undergo an annual verification and management certification process to be considered for admission.
DTC (Depository Trust Company) eligibility enables simplified electronic clearing and settlement of common shares for U.S. investors, which Innovotech will apply for in conjunction with its OTCQB listing.
Innovotech Inc. is a Canadian boutique contract research organization specializing in advanced laboratory services and commercializing proprietary technologies, with expertise in biofilm science, antimicrobial testing, pharmaceutical analysis, and industrial laboratory solutions.
Innovotech's primary listing is on the TSXV (TSX Venture Exchange) under the symbol IOT, and the OTCQB quotation will operate in parallel with this Canadian listing without replacing it.
Investors can contact Craig Milne, CEO of Innovotech Inc., at +1-604-239-1819 or craig.milne@innovotech.ca for more information.
Curated from NewMediaWire
